X0303 5 2009-12-31 0 0 1 0001031927 Echo Therapeutics, Inc. ECTE 0001278255 MOONEY PATRICK T C/O ECHO THERAPEUTICS, INC. 10 FORGE PARKWAY FRANKLIN MA 02038 1 1 0 0 CEO and President Common stock 2009-02-20 4 A 0 L 350000 0 A 1850907 D Common stock 2009-06-15 4 A 0 L 375000 0 A 1850907 D Non-qualified stock option 2.39 2009-02-20 4 D 0 L 500000 2.39 A 2017-09-14 Common stock 500000 1850907 D One third of the options vested on September 14, 2007, one-third of the options vested on September 14, 2008, and the remainder would have vested on September 14, 2009. Includes 500,000 shares that may be acquired by Dr. Mooney within 60 days upon the exercise of stock options. The restricted shares shall vest upon the first to occur of (i) FDA approval of the Companys Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities. Kimberly A. Burke, by power of attorney 2010-04-30